Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Edwards Lifesciences Corporation (EW) stocks in Canada
Learn how to easily invest in Edwards Lifesciences Corporation stocks.
Edwards Lifesciences Corporation is a medical devices business based in the US. Edwards Lifesciences Corporation stocks (EW.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $130.68 – a decrease of 6% over the previous week. Edwards Lifesciences Corporation employs 14,900 staff and has a trailing 12-month revenue of around $5.1 billion.
How to buy shares in Edwards Lifesciences Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EW – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Edwards Lifesciences Corporation?
- Has coronavirus impacted Edwards Lifesciences Corporation shares?
- Edwards Lifesciences Corporation shares summary
- Compare share dealing platforms
- Is Edwards Lifesciences Corporation stock a buy or sell?
- Edwards Lifesciences Corporation performance over time
- Is Edwards Lifesciences Corporation suitable for ethical investing?
- Are Edwards Lifesciences Corporation shares over-valued?
- Edwards Lifesciences Corporation's financials
- How volatile are Edwards Lifesciences Corporation shares?
- Does Edwards Lifesciences Corporation pay a dividend?
- Have Edwards Lifesciences Corporation shares ever split?
- Other common questions
Edwards Lifesciences Corporation stock price (NYSE:EW)Use our graph to track the performance of EW stocks over time.
Edwards Lifesciences Corporation shares at a glance
|Latest market close||$108.63|
|52-week range||$78.44 - $131.73|
|50-day moving average||$119.23|
|200-day moving average||$109.87|
|Wall St. target price||$129.52|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.33|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Edwards Lifesciences Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Edwards Lifesciences Corporation price performance over time
|1 week (2022-01-20)||-6.00%|
|1 month (2021-12-27)||-16.81%|
|3 months (2021-10-26)||-7.15%|
|6 months (2021-07-27)||-1.16%|
|1 year (2021-01-27)||28.04%|
|2 years (2020-01-27)||-52.55%|
|3 years (2019-01-25)||170.64|
|5 years (2017-01-27)||11.64%|
Is Edwards Lifesciences Corporation under- or over-valued?
Valuing Edwards Lifesciences Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Edwards Lifesciences Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Edwards Lifesciences Corporation's P/E ratio
Edwards Lifesciences Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Edwards Lifesciences Corporation shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Edwards Lifesciences Corporation's PEG ratio
Edwards Lifesciences Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5631. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Edwards Lifesciences Corporation's EBITDA
Edwards Lifesciences Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.7 billion.
The EBITDA is a measure of a Edwards Lifesciences Corporation's overall financial performance and is widely used to measure a its profitability.
Edwards Lifesciences Corporation financials
|Revenue TTM||$5.1 billion|
|Operating margin TTM||31.1%|
|Gross profit TTM||$3.3 billion|
|Return on assets TTM||13.24%|
|Return on equity TTM||3029.86%|
|Market capitalisation||$72.1 billion|
TTM: trailing 12 months
Edwards Lifesciences Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Edwards Lifesciences Corporation's total ESG risk score
Total ESG risk: 21.68
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences Corporation's overall score of 21.68 (as at 01/01/2019) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Edwards Lifesciences Corporation's environmental score
Environmental score: 4.78/100
Edwards Lifesciences Corporation's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Edwards Lifesciences Corporation's social score
Social score: 13.43/100
Edwards Lifesciences Corporation's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Edwards Lifesciences Corporation's governance score
Governance score: 10.96/100
Edwards Lifesciences Corporation's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Edwards Lifesciences Corporation's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Edwards Lifesciences Corporation scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences Corporation has, for the most part, managed to keep its nose clean.
Edwards Lifesciences Corporation share dividends
We're not expecting Edwards Lifesciences Corporation to pay a dividend over the next 12 months.
Have Edwards Lifesciences Corporation's shares ever split?
Edwards Lifesciences Corporation's shares were split on a 3:1 basis on 1 June 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences Corporation shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences Corporation shares which in turn could have impacted Edwards Lifesciences Corporation's share price.
Edwards Lifesciences Corporation share price volatility
Over the last 12 months, Edwards Lifesciences Corporation's shares have ranged in value from as little as $78.44 up to $131.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences Corporation's is 1.0933. This would suggest that Edwards Lifesciences Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Edwards Lifesciences Corporation overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. .
Stocks similar to Edwards Lifesciences Corporation
Edwards Lifesciences Corporation in the news
Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook
Edwards Lifesciences (EW) Q4 2021 Earnings Call Transcript
Top Analyst Reports for AbbVie, Edwards Lifesciences & Johnson Controls
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Ask an Expert
You must be logged in to post a comment.